A genome-scale CRISPR-Cas9 screening method for protein stability reveals novel regulators of Cdc25A

被引:27
|
作者
Wu, Yuanzhong [1 ]
Zhou, Liwen [1 ]
Wang, Xin [1 ]
Lu, Jinping [2 ,3 ]
Zhang, Ruhua [1 ]
Liang, Xiaoting [1 ]
Wang, Li [1 ]
Deng, Wuguo [1 ]
Zeng, Yi-Xin [1 ]
Huang, Haojie [1 ,4 ]
Kang, Tiebang [1 ,5 ]
机构
[1] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China
[2] Jinan Univ, Zhuhai Hosp, Zhuhai Peoples Hosp, Clin Lab, Zhuhai, Peoples R China
[3] Jinan Univ, Med Res Ctr, Zhuhai, Peoples R China
[4] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN USA
[5] Guangzhou Doublle Bioprod Co Ltd, Guangdong Prov Key Lab Tumor Targeted Drugs, Guangzhou, Guangdong, Peoples R China
关键词
acetylation; Cdc25A; CRISPR-Cas9; screening; protein stability; ubiquitination; SCF UBIQUITIN LIGASE; BETA-TRCP; DEGRADATION; CELLS; NETWORKS; INSIGHTS;
D O I
10.1038/celldisc.2016.14
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The regulation of stability is particularly crucial for unstable proteins in cells. However, a convenient and unbiased method of identifying regulators of protein stability remains to be developed. Recently, a genome-scale CRISPR-Cas9 library has been established as a genetic tool to mediate loss-of-function screening. Here, we developed a protein stability regulators screening assay (Pro-SRSA) by combining the whole-genome CRISPR-Cas9 library with a dual-fluorescence-based protein stability reporter and high-throughput sequencing to screen for regulators of protein stability. Using Cdc25A as an example, Cul4B-DDB1DCAF8 was identified as a new E3 ligase for Cdc25A. Moreover, the acetylation of Cdc25A at lysine 150, which was acetylated by p300/CBP and deacetylated by HDAC3, prevented the ubiquitin-mediated degradation of Cdc25A by the proteasome. This is the first study to report that acetylation, as a novel posttranslational modification, modulates Cdc25A stability, and we suggest that this unbiased CRISPR-Cas9 screening method at the genome scale may be widely used to globally identify regulators of protein stability.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] A genome-scale CRISPR-Cas9 screening method for protein stability reveals novel regulators of Cdc25A
    Yuanzhong Wu
    Liwen Zhou
    Xin Wang
    Jinping Lu
    Ruhua Zhang
    Xiaoting Liang
    Li Wang
    Wuguo Deng
    Yi-Xin Zeng
    Haojie Huang
    Tiebang Kang
    Cell Discovery, 2
  • [2] A genome-scale CRISPR-Cas9 screening method for protein stability reveals novel regulators of Cdc25A
    Wu, Yuanzhong
    Kang, Tiebang
    CANCER RESEARCH, 2016, 76
  • [3] Genome-Scale CRISPR-Cas9 Screening in Human Cells
    Sanjana, Neville E.
    Shalem, Ophir
    Hartenian, Ella
    Shi, Xi
    Scott, David A.
    Zhang, Feng
    Zhang, Feng
    MOLECULAR THERAPY, 2014, 22 : S123 - S124
  • [4] Identifying novel regulators of the Unfolded Protein Response (UPR) by genome-scale CRISPR-Cas9 knockout screens
    Leli, Nektaria Maria
    Dey, Souvik
    Brady, Lauren
    Koumenis, Constantinos
    CANCER RESEARCH, 2017, 77
  • [5] Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening
    Julia Joung
    Silvana Konermann
    Jonathan S Gootenberg
    Omar O Abudayyeh
    Randall J Platt
    Mark D Brigham
    Neville E Sanjana
    Feng Zhang
    Nature Protocols, 2017, 12 : 828 - 863
  • [6] Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
    Shalem, Ophir
    Sanjana, Neville E.
    Hartenian, Ella
    Shi, Xi
    Scott, David A.
    Mikkelsen, Tarjei S.
    Heckl, Dirk
    Ebert, Benjamin L.
    Root, David E.
    Doench, John G.
    Zhang, Feng
    SCIENCE, 2014, 343 (6166) : 84 - 87
  • [7] Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening
    Joung, Julia
    Konermann, Silvana
    Gootenberg, Jonathan S.
    Abudayyeh, Omar O.
    Platt, Randall J.
    Brigham, Mark D.
    Sanjana, Neville E.
    Zhang, Feng
    NATURE PROTOCOLS, 2017, 12 (04) : 828 - 863
  • [8] A genome-scale CRISPR-Cas9 screening in myeloma cells identifies regulators of immunomodulatory drug sensitivity
    Liu, Jiye
    Song, Tianyu
    Zhou, Wenrong
    Xing, Lijie
    Wang, Su
    Ho, Matthew
    Peng, Zhengang
    Tai, Yu-Tzu
    Hideshima, Teru
    Anderson, Kenneth C.
    Cang, Yong
    LEUKEMIA, 2019, 33 (01) : 171 - 180
  • [9] A genome-scale CRISPR-Cas9 screening in myeloma cells identifies regulators of immunomodulatory drug sensitivity
    Jiye Liu
    Tianyu Song
    Wenrong Zhou
    Lijie Xing
    Su Wang
    Matthew Ho
    Zhengang Peng
    Yu-Tzu Tai
    Teru Hideshima
    Kenneth C. Anderson
    Yong Cang
    Leukemia, 2019, 33 : 171 - 180
  • [10] Genome-scale CRISPR-Cas9 screen reveals novel regulators of B7-H3 in tumor cells
    Zhao, Shasha
    Wang, Yuelong
    Yang, Nian
    Mu, Min
    Wu, Zhiguo
    Li, Hexian
    Tang, Xin
    Zhong, Kunhong
    Zhang, Zongliang
    Huang, Cheng
    Cao, Ting
    Zheng, Meijun
    Wang, Guoqing
    Nie, Chunlai
    Yang, Hui
    Guo, Gang
    Zhou, Liangxue
    Zheng, Xi
    Tong, Aiping
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (06)